cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA247828 | .a | 4677 to 4861 | 25 to 208 | 184/208 (88 %) | 6 diff (97.2 %id) | ||||
AA314461 | colon | .a | 3747 to 4262 | 1 to 516 | 516/516 (100 %) | 0 diff (100 %id) | |||
AW954851 | .a | 3774 to 4310 | 1 to 537 | tiling clone, | 537/576 (93 %) | 9 diff (98.5 %id) | |||
AW968229 | .a | 2572 to 3126 | 1 to 555 | 555/555 (100 %) | 16 diff (97.2 %id) | ||||
AW968972 | .a | 2572 to 3102 | 1 to 530 | tiling clone, | 530/530 (100 %) | 8 diff (98.5 %id) | |||
BG944479 | blood | .a | 94 to 427 | 1 to 334 | 334/334 (100 %) | 0 diff (100 %id) | |||
BE148232 | head_neck | .c-u | 1028 to 1642 | 1 to 614 | 614/614 (100 %) | 17 diff (97.3 %id) | |||
BE181924 | head_neck | .c-u | 1624 to 1929 | 307 to 1 | Submitted on the opposite strand | 307/307 (100 %) | 11 diff (96.5 %id) | ||
BF230019 | colon | .a | 7637 to 8017 | 24 to 407 | 384/412 (93 %) | 9 diff (97.9 %id) | |||
BF857833 | prostate_tumor | .c-u | 1519 to 1976 | 460 to 6 | Submitted on the opposite strand | 455/460 (98 %) | 0 diff (100 %id) | ||
BF949457 | nervous_normal | .a | 5934 to 6187 | 263 to 11 | 253/288 (87 %) | 0 diff (100 %id) | |||
BF949580 | nervous_normal | .a | 5934 to 6183 | 262 to 13 | 250/286 (87 %) | 0 diff (100 %id) | |||
BF951027 | nervous_normal | .f | 1 to 499 | 14 to 513 | L9W F22C D24E L29V R41K ... | tiling clone, | 500/514 (97 %) | 24 diff (95.4 %id) | |
BG196816 | .a | 7389 to 8323 | 10 to 914 | 905/980 (92 %) | 11 diff (98.9 %id) | ||||
BG953369 | colon | .c-u | 1978 to 2240 | 266 to 5 | 262/266 (98 %) | 0 diff (100 %id) | |||
BG979854 | colon_normal | .f | 478 to 771 | 295 to 3 | 293/295 (99 %) | 0 diff (100 %id) | |||
BI023758 | marrow | .c-u | 1512 to 1915 | 410 to 6 | 405/410 (98 %) | 0 diff (100 %id) | |||
BI040861 | nervous_tumor | .f | 258 to 899 | 641 to 6 | tiling clone, | 636/717 (88 %) | 0 diff (100 %id) | ||
DA044004 | bladder | .b | 3674 to 4166 | 2 to 494 | capped | 493/493 (100 %) | 3 diff (99.4 %id) | ||
DB296091 | bladder | .b | 5098 to 5633 | 536 to 1 | tiling clone, | 536/536 (100 %) | 2 diff (99.7 %id) | ||
DA291909 | hippocampus | .a | 5780 to 6361 | 2 to 583 | capped | 582/582 (100 %) | 0 diff (100 %id) | ||
DA328688 | hippocampus | .a | 4724 to 5273 | 2 to 551 | tiling clone, capped | 550/550 (100 %) | 0 diff (100 %id) | ||
DB309517 | hippocampus | .a | 7905 to 8463 | 561 to 1 | 561/561 (100 %) | 2 diff (99.7 %id) | |||
DA353582 | substantia nigra | .b | 4822 to 5338 | 2 to 518 | tiling clone, capped | 517/517 (100 %) | 0 diff (100 %id) | ||
DA413316 | thalamus | .f | 328 to 868 | 2 to 542 | tiling clone, capped | 541/541 (100 %) | 1 diff (99.9 %id) | ||
BX095016 | lung | .a | 2823 to 3336 | 1 to 514 | 514/514 (100 %) | 0 diff (100 %id) | |||
Z41501 | brain, total brain | .a | 2593 to 2887 | 1 to 295 | 295/295 (100 %) | 2 diff (99.4 %id) | |||
CD629351 | .g-u | 1 to 621 | 17 to 646 | exact | tiling clone, | 630/646 (97 %) | 6 diff (99.1 %id) | ||
CN264965 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 2836 to 3427 | 21 to 612 | tiling clone, | 592/612 (96 %) | 7 diff (98.9 %id) | ||
CN267004 | embryonic stem cells, cell lines H1, H7, andH9 | .i | 1 to 452 | 1 to 452 | exact | tiling clone, | 452/452 (100 %) | 0 diff (100 %id) | |
CN269110 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 4286 to 4760 | 1 to 475 | 475/475 (100 %) | 0 diff (100 %id) | |||
CN279092 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 5854 to 6501 | 1 to 648 | tiling clone, | 648/648 (100 %) | 0 diff (100 %id) | ||
CN279093 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 5337 to 6042 | 1 to 706 | tiling clone, | 706/706 (100 %) | 2 diff (99.8 %id) | ||
CN280244 | embryonic stem cells, DMSO-treated H9 cellline | .a | 170 to 902 | 1 to 733 | 733/733 (100 %) | 0 diff (100 %id) | |||
CN280245 | embryonic stem cells, cell lines H1, H7, andH9 | .e | 1 to 449 | 1 to 449 | exact | tiling clone, | 449/449 (100 %) | 0 diff (100 %id) | |
CN289854 | embryonic stem cells, DMSO-treated H9 cellline | .c-u | 2401 to 3011 | 3 to 612 | tiling clone, | 610/616 (99 %) | 3 diff (99.6 %id) | ||
CN294844 | embryonic stem cells, DMSO-treated H9 cellline | .a | 34 to 280 | 1 to 247 | 247/247 (100 %) | 0 diff (100 %id) | |||
CN369540 | embryonic stem cells, DMSO-treated H9 cellline | .c-u | 2340 to 2737 | 5 to 402 | 398/402 (99 %) | 6 diff (98.6 %id) | |||
CN369541 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .c-u | 2221 to 2742 | 1 to 522 | tiling clone, | 522/522 (100 %) | 0 diff (100 %id) | ||
CN413586 | embryonic stem cells, cell lines H1, H7, andH9 | .h | 1 to 617 | 1 to 616 | exact | tiling clone, | 616/616 (100 %) | 3 diff (99.6 %id) | |
BX333988 | Neuroblastoma Cot 50-normalized | .c-u | 1615 to 2425 | 1 to 811 | 811/811 (100 %) | 0 diff (100 %id) | |||
BX345112 | Neuroblastoma Cot 50-normalized | .c-u | 1615 to 2463 | 1 to 848 | 848/848 (100 %) | 5 diff (99.5 %id) | |||
BX387160 | Neuroblastoma Cot 50-normalized | .c-u | 1615 to 2632 | 1 to 1013 | 1013/1013 (100 %) | 12 diff (98.9 %id) | |||
BX341143 | .a | 1 to 1057 | 1 to 1044 | tiling clone, | 1044/1063 (98 %) | 20 diff (98.2 %id) | |||
BX431733 | fetal liver, Liver | .c-u | 827 to 1755 | 1 to 922 | tiling clone, | 922/922 (100 %) | 14 diff (98.5 %id) | ||
BX447400 | fetal liver, Liver | .c-u | 1 to 844 | 1 to 845 | 845/1115 (75 %) | 14 diff (98.8 %id) | |||
BX462881 | fetal liver, Liver | .c-u | 1 to 1091 | 1 to 1076 | tiling clone, | 1076/1076 (100 %) | 24 diff (97.8 %id) | ||
CV024664 | mixed | .c-u | 1351 to 1909 | 1 to 559 | 559/566 (98 %) | 3 diff (99.5 %id) | |||
CV316608 | uterus_tumor | .c-u | 1421 to 1861 | 1 to 439 | 439/439 (100 %) | 4 diff (99.1 %id) | |||
CV344467 | prostate_normal | .c-u | 2681 to 2893 | 215 to 4 | Submitted on the opposite strand | 212/215 (98 %) | 0 diff (100 %id) | ||
CV366429 | testis_normal | .c-u | 1407 to 1896 | 10 to 493 | 484/499 (96 %) | 6 diff (98.8 %id) | |||
CV370914 | testis_normal | .c-u | 148 to 286 | 138 to 1 | Submitted on the opposite strand | 138/138 (100 %) | 4 diff (97.2 %id) | ||
BX488985 | .a | 3499 to 3964 | 1 to 466 | 466/466 (100 %) | 0 diff (100 %id) | ||||
BX481780 | .a | 3186 to 3818 | 20 to 651 | 632/651 (97 %) | 6 diff (99.1 %id) | ||||
BX484216 | .a | 3226 to 3739 | 1 to 515 | 515/515 (100 %) | 7 diff (98.7 %id) | ||||
BX495297 | Liver | .a | 3599 to 4227 | 1 to 628 | 628/628 (100 %) | 4 diff (99.4 %id) | |||
BX495492 | Liver | .a | 3456 to 3972 | 1 to 515 | 515/515 (100 %) | 5 diff (99.1 %id) | |||
R57137 | .a | 4285 to 4435 | 1 to 151 | 151/151 (100 %) | 2 diff (98.7 %id) | ||||
FN073861 | breast carcinoma | .a | 4023 to 4096 | 14 to 87 | 74/87 (85 %) | 6 diff (93.2 %id) | |||
GD156710 | .a | 3804 to 3884 | 8 to 88 | 81/89 (91 %) | 4 diff (95.6 %id) | ||||
GD156718 | .a | 3804 to 3881 | 8 to 85 | 78/85 (91 %) | 6 diff (93.0 %id) | ||||
AV687344 | hepatocellular carcinoma | .a | 2346 to 2957 | 1 to 610 | 610/618 (98 %) | 5 diff (99.2 %id) | |||
AV690587 | hepatocellular carcinoma | .a | 2346 to 2759 | 1 to 416 | 416/416 (100 %) | 7 diff (98.4 %id) | |||
BP397642 | pancreatic islet | .a | 7375 to 7869 | 497 to 1 | 497/499 (99 %) | 3 diff (99.4 %id) | |||
DB445276 | testis | .h | 13 to 443 | 1 to 431 | tiling clone, | 431/431 (100 %) | 5 diff (98.9 %id) | ||
DB510299 | testis | .b | 4411 to 4705 | 1 to 297 | Submitted on the opposite strand | 297/297 (100 %) | 6 diff (98.0 %id) | ||
DB513466 | testis | .a | 7375 to 7724 | 351 to 3 | 349/354 (98 %) | 0 diff (100 %id) | |||
DB487467 | hypothalamus | .a | 56 to 500 | 1 to 445 | 445/445 (100 %) | 2 diff (99.6 %id) | |||
DB556829 | hypothalamus | .b | 4263 to 4705 | 1 to 444 | Submitted on the opposite strand | 444/444 (100 %) | 6 diff (98.7 %id) | ||
DB558556. matches multiple genes | hypothalamus | .a | 7378 to 7818 | 442 to 1 | also hits gene FAM92A1 | 442/443 (99 %) | 2 diff (99.6 %id) | ||
DB501223 | hypothalamus | .a | 56 to 547 | 1 to 492 | 492/492 (100 %) | 2 diff (99.6 %id) | |||
DB572412 | hypothalamus | .b | 4224 to 4705 | 1 to 483 | Submitted on the opposite strand | 483/483 (100 %) | 1 diff (99.8 %id) | ||
BY797161 | eye | .e | 4 to 588 | 1 to 585 | tiling clone, | 585/585 (100 %) | 2 diff (99.7 %id) | ||
BP423524 | small intestine | .c-u | 1464 to 2011 | 1 to 549 | Submitted on the opposite strand | 549/549 (100 %) | 1 diff (99.9 %id) | ||
CD678930 | eye, Trabecular meshwork | .a | 3375 to 3850 | 497 to 22 | fully sequenced, AAA | 476/476 (100 %) | 0 diff (100 %id) | ||
CD678931 | eye, Trabecular meshwork | .a | 2923 to 3405 | 1 to 483 | fully sequenced, | 483/483 (100 %) | 0 diff (100 %id) | ||
H12319 | placenta | .a | 2139 to 2540 | 406 to 4 | 403/479 (84 %) | 0 diff (100 %id) | |||
H12760 | placenta | .a | 7696 to 8093 | 404 to 1 | 404/447 (90 %) | 13 diff (97.1 %id) | |||
H12803 | placenta | .a | 7303 to 7664 | 1 to 367 | 367/437 (83 %) | 8 diff (98.2 %id) | |||
H00440 | placenta | .a | 2139 to 2535 | 398 to 1 | tiling clone, | 398/462 (86 %) | 5 diff (99.0 %id) | ||
N36928 | melanocyte | .a | 3284 to 3850 | 580 to 2 | 579/582 (99 %) | 0 diff (100 %id) | |||
N46201 | melanocyte | .a | 2644 to 3072 | 1 to 427 | 427/428 (99 %) | 2 diff (99.6 %id) | |||
N51505 | multiple sclerosis lesions | .a | 3471 to 3850 | 385 to 1 | 385/497 (77 %) | 10 diff (98.0 %id) | |||
N53648 | multiple sclerosis lesions | .a | 2995 to 3116 | 1 to 122 | 122/125 (97 %) | 1 diff (99.2 %id) | |||
W23872. matches multiple genes | lung | .a | 2823 to 2981 | 1 to 159 | also hits gene RBM9 | 159/159 (100 %) | 0 diff (100 %id) | ||
N94814 | lung | .a | 3349 to 3868 | 530 to 1 | Submitted on the opposite strand | 530/537 (98 %) | 17 diff (96.9 %id) | ||
AA287772 | germinal center B cell | .f | 807 to 1313 | 505 to 1 | tiling clone, | Submitted on the opposite strand | 505/505 (100 %) | 4 diff (99.3 %id) | |
AA406490 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3465 to 3912 | 1 to 448 | 448/448 (100 %) | 0 diff (100 %id) | |||
AA406491 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 4238 to 4724 | 486 to 1 | tiling clone, | 486/486 (100 %) | 1 diff (99.8 %id) | ||
AA905951 | pooled | .b | 4369 to 4710 | 346 to 5 | 342/346 (98 %) | 9 diff (97.4 %id) | |||
AA922008 | pooled | .a | 4333 to 4720 | 388 to 1 | 388/388 (100 %) | 0 diff (100 %id) | |||
AA928273 | pooled | .a | 7610 to 8093 | 484 to 1 | tiling clone, | 484/484 (100 %) | 1 diff (99.8 %id) | ||
AI087259 | senescent fibroblast | .b | 4283 to 4710 | 432 to 4 | tiling clone, | 429/432 (99 %) | 0 diff (100 %id) | ||
AI199793 | placenta | .f | 4 to 443 | 443 to 4 | exact | tiling clone, | 440/443 (99 %) | 0 diff (100 %id) | |
AI312611 | lung | .a | 3428 to 3856 | 430 to 2 | 429/430 (99 %) | 0 diff (100 %id) | |||
AI382091 | pooled | .b | 4282 to 4710 | 430 to 2 | 429/430 (99 %) | 0 diff (100 %id) | |||
AI700123 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .a | 2173 to 2585 | 414 to 2 | 413/414 (99 %) | 0 diff (100 %id) | |||
AI810636 | Prostate | .a | 3293 to 3841 | 562 to 14 | AAA | 549/549 (100 %) | 0 diff (100 %id) | ||
AI673373 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 2137 to 2585 | 450 to 2 | tiling clone, | 449/450 (99 %) | 0 diff (100 %id) | ||
AI913932 | colon | .a | 3471 to 3841 | 371 to 1 | 371/371 (100 %) | 0 diff (100 %id) | |||
AI798667 | pooled | .a | 7678 to 8093 | 416 to 1 | 416/416 (100 %) | 1 diff (99.8 %id) | |||
AI807494 | pooled | .b | 4186 to 4708 | 523 to 1 | tiling clone, | 523/523 (100 %) | 6 diff (98.9 %id) | ||
AI858294 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 2115 to 2585 | 473 to 2 | 472/473 (99 %) | 0 diff (100 %id) | |||
AI889787 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 2186 to 2585 | 401 to 2 | 400/401 (99 %) | 0 diff (100 %id) | |||
AI961487 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 7983 to 8475 | 493 to 1 | tiling clone, | 493/493 (100 %) | 1 diff (99.8 %id) | ||
AW173474 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 8019 to 8467 | 449 to 1 | tiling clone, | 449/449 (100 %) | 0 diff (100 %id) | ||
AW242318 | Kidney | .a | 4140 to 4723 | 585 to 1 | 585/585 (100 %) | 7 diff (98.9 %id) | |||
AW303970 | pooled | .a | 7624 to 8093 | 470 to 1 | 470/470 (100 %) | 2 diff (99.6 %id) | |||
CF135883 | lymph | .c-u | 2071 to 2728 | 8 to 659 | 652/659 (98 %) | 6 diff (99.1 %id) | |||
BE549821 | pooled germ cell tumors | .b | 4223 to 4705 | 483 to 1 | 483/483 (100 %) | 0 diff (100 %id) | |||
BE550368 | pooled germ cell tumors | .a | 2083 to 2585 | 503 to 1 | 503/503 (100 %) | 1 diff (99.9 %id) | |||
BF063208 | colon, colon tumor, RER+ | .b | 4220 to 4710 | 492 to 2 | 491/492 (99 %) | 0 diff (100 %id) | |||
BF243229 | bone marrow, from acute myelogenous leukemia | .a | 6975 to 7652 | 1 to 676 | tiling clone, | 676/913 (74 %) | 23 diff (97.5 %id) | ||
BG252075 | adenocarcinoma, cell line, Liver | .a | 7029 to 7686 | 1 to 653 | 653/914 (71 %) | 10 diff (99.0 %id) | |||
BG687636 | lung, mucoepidermoid carcinoma | .a | 6605 to 7269 | 1 to 664 | 664/665 (99 %) | 3 diff (99.6 %id) | |||
BC039260 | Brain, hypothalamus | .b | 1 to 4705 | 1 to 4702 | S250F R605C R628G R629G P630L ... | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 4702/4702 (100 %) | 14 diff (99.8 %id) |
BI600286 | brain, hypothalamus | .a | 51 to 759 | 1 to 711 | available from MGC, | 711/711 (100 %) | 13 diff (98.2 %id) | ||
BM561108 | eye, retinoblastoma | .a | 7958 to 8463 | 60 to 565 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 506/565 (89 %) | 6 diff (99.0 %id) | |
BM921102 | pooled brain, lung, testis | .a | 2176 to 2576 | 12 to 412 | 401/412 (97 %) | 6 diff (98.6 %id) | |||
CK825544 | Pancreas, Purified pancreatic islet | .a | 3297 to 3860 | 569 to 6 | 564/569 (99 %) | 0 diff (100 %id) | |||
BU790011 | Pancreas, Purified pancreatic islet | .a | 4107 to 4722 | 616 to 1 | 616/616 (100 %) | 0 diff (100 %id) | |||
BU790311 | Pancreas, Purified pancreatic islet | .a | 3411 to 4076 | 1 to 666 | tiling clone, | 666/666 (100 %) | 3 diff (99.6 %id) | ||
BU506977 | leiomyosarcoma, uterus | .c-u | 1504 to 2393 | 1 to 891 | tiling clone, | 891/898 (99 %) | 5 diff (99.5 %id) | ||
BU508481 | leiomyosarcoma, uterus | .a | 1689 to 2284 | 1 to 606 | tiling clone, | 606/1125 (53 %) | 19 diff (98.4 %id) | ||
CA950671 | Pancreas, Purified pancreatic islet | .a | 4264 to 4719 | 456 to 1 | 456/456 (100 %) | 0 diff (100 %id) | |||
CX163833 | human embryonic stem cells differentiated toan early endodermal cell type | .c-u | 1905 to 2735 | 1 to 831 | 831/831 (100 %) | 0 diff (100 %id) | |||
CD653104 | Embryonic Stem cells | .c-u | 1867 to 2638 | 11 to 782 | 772/783 (98 %) | 9 diff (98.9 %id) | |||
DA608887 | .a | 6581 to 7146 | 2 to 567 | capped | 566/566 (100 %) | 1 diff (99.9 %id) | |||
DB320096 | .a | 7908 to 8463 | 556 to 1 | 556/556 (100 %) | 0 diff (100 %id) | ||||
TI_45211477 | .a | 58 to 759 | 135 to 838 | 704/838 (84 %) | 14 diff (98.4 %id) | ||||
CB136060 | Liver | .a | 3033 to 3662 | 1 to 629 | 629/629 (100 %) | 2 diff (99.7 %id) | |||
NM_203390.2 | .a | 22 to 5120 | 1 to 5099 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 5099/5099 (100 %) | 0 diff (100 %id) | |
DA805675 | brain | .b | 4438 to 4980 | 2 to 544 | tiling clone, capped | 543/543 (100 %) | 1 diff (99.9 %id) | ||
CV572156 | cornea, eye | .a | 6874 to 7518 | 1 to 645 | tiling clone, | 645/645 (100 %) | 2 diff (99.7 %id) | ||
CK431143 | eye, lacrimal gland | .a | 6641 to 7009 | 1 to 373 | 373/373 (100 %) | 9 diff (97.6 %id) | |||
CK431164 | eye, lacrimal gland | .a | 6501 to 7099 | 1 to 599 | tiling clone, | 599/599 (100 %) | 0 diff (100 %id) | ||
DA881980 | .a | 5327 to 5872 | 2 to 548 | tiling clone, capped | 547/547 (100 %) | 1 diff (99.9 %id) | |||
DB330371 | .a | 7945 to 8463 | 519 to 1 | 519/519 (100 %) | 0 diff (100 %id) | ||||
TI_1948141819 | .c-u | 1349 to 2154 | 131 to 933 | 803/1287 (62 %) | 26 diff (98.0 %id) | ||||
TI_1948141820 | .c-u | 1349 to 2176 | 125 to 967 | 843/1298 (64 %) | 50 diff (96.2 %id) | ||||
TI_1948141822 | .b | 1563 to 2457 | 1033 to 128 | 906/1377 (65 %) | 30 diff (97.9 %id) | ||||
TI_1948142145 | .c-u | 1349 to 1996 | 129 to 779 | 651/1252 (51 %) | 11 diff (99.2 %id) | ||||
TI_1948142146 | .c-u | 1349 to 2300 | 128 to 1062 | 935/1280 (73 %) | 32 diff (97.5 %id) | ||||
TI_1948142147 | .b | 1457 to 2457 | 1119 to 127 | 993/1313 (75 %) | 29 diff (97.8 %id) | ||||
TI_1948142148 | .b | 1456 to 2457 | 1123 to 126 | 998/1332 (74 %) | 35 diff (97.4 %id) | ||||
TI_1948142489 | .c-u | 1349 to 2024 | 124 to 797 | 674/1357 (49 %) | 24 diff (98.3 %id) | ||||
TI_1948142490 | .c-u | 1349 to 2279 | 118 to 1057 | AAA | 940/1321 (71 %) | 35 diff (97.4 %id) | |||
TI_1948142491 | .b | 1482 to 2457 | 1113 to 128 | 986/1357 (72 %) | 49 diff (96.4 %id) | ||||
TI_1948142492 | .b | 1590 to 2457 | 1002 to 131 | 872/1299 (67 %) | 30 diff (97.7 %id) | ||||
TI_1948142823 | .c-u | 1342 to 2040 | 113 to 810 | 698/1333 (52 %) | 6 diff (99.6 %id) | ||||
TI_1948142824 | .c-u | 1342 to 2236 | 113 to 1010 | AAA | 898/1323 (67 %) | 7 diff (99.5 %id) | |||
TI_1948142825 | .b | 1438 to 2457 | 1130 to 127 | 1004/1300 (77 %) | 39 diff (97.0 %id) | ||||
TI_1948142826 | .b | 1471 to 2457 | 1117 to 127 | 991/1435 (69 %) | 33 diff (97.8 %id) | ||||
TI_1948155515 | .c-u | 1445 to 1958 | 220 to 735 | 516/1366 (37 %) | 50 diff (96.4 %id) | ||||
DR002372 | fetal brain | .d | 1 to 586 | 1 to 586 | G2E P3A | tiling clone, | 586/586 (100 %) | 5 diff (99.2 %id) | |
DR002144 | fetal brain | .c-u | 1328 to 1942 | 9 to 623 | 615/623 (98 %) | 6 diff (99.1 %id) | |||
BM145393 | leukopheresis | .a | 7377 to 7880 | 17 to 521 | tiling clone, | 505/532 (94 %) | 7 diff (98.7 %id) | ||
DB105228 | thymus | .a | 6069 to 6618 | 2 to 551 | capped | 550/550 (100 %) | 0 diff (100 %id) | ||
DB342821 | thymus | .a | 7882 to 8463 | 582 to 1 | 582/592 (98 %) | 0 diff (100 %id) | |||
TI_149286816 | .a | 3162 to 3869 | 789 to 84 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 706/1186 (59 %) | 10 diff (99.2 %id) | ||
TI_154077858 | .a | 1978 to 2585 | 671 to 65 | 607/672 (90 %) | 0 diff (100 %id) | ||||
TI_154164531 | .c-u | 2071 to 2837 | 77 to 824 | 748/893 (83 %) | 21 diff (97.7 %id) | ||||
BU681085 | lung | .a | 3340 to 3869 | 546 to 17 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 530/530 (100 %) | 0 diff (100 %id) | |
BM713201 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5630 to 6048 | 1 to 419 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 419/419 (100 %) | 0 diff (100 %id) | |
BM713325 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5630 to 6048 | 1 to 419 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 419/422 (99 %) | 1 diff (99.8 %id) | |
BQ574154 | Chondrosarcoma Grade II, Left Pelvis | .b | 4086 to 4705 | 638 to 19 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 620/620 (100 %) | 2 diff (99.7 %id) | |
AV702048 | adrenal gland | .a | 7945 to 8463 | 519 to 1 | Suspected internal deletion, this clone was ignored | 519/519 (100 %) | 0 diff (100 %id) | ||
AW968721 | .c-u | 1349 to 2154 | 131 to 933 | Suspected internal deletion, this clone was ignored | 803/1287 (62 %) | 26 diff (98.0 %id) | |||
AI207139 | pooled germ cell tumors | .c-u | 1349 to 2176 | 125 to 967 | Suspected internal deletion, this clone was ignored | 843/1298 (64 %) | 50 diff (96.2 %id) | ||
AI870093 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .b | 1563 to 2457 | 1033 to 128 | Suspected internal deletion, this clone was ignored | 906/1377 (65 %) | 30 diff (97.9 %id) | ||
BQ069253 | brain, neuroblastoma, cell line | .c-u | 1349 to 1996 | 129 to 779 | 651/1252 (51 %) | 11 diff (99.2 %id) | |||
TI_1948142146 | .c-u | 1349 to 2300 | 128 to 1062 | 935/1280 (73 %) | 32 diff (97.5 %id) | ||||
TI_1948142147 | .b | 1457 to 2457 | 1119 to 127 | 993/1313 (75 %) | 29 diff (97.8 %id) | ||||
TI_1948142148 | .b | 1456 to 2457 | 1123 to 126 | 998/1332 (74 %) | 35 diff (97.4 %id) | ||||
TI_1948142489 | .c-u | 1349 to 2024 | 124 to 797 | 674/1357 (49 %) | 24 diff (98.3 %id) | ||||
TI_1948142490 | .c-u | 1349 to 2279 | 118 to 1057 | AAA | 940/1321 (71 %) | 35 diff (97.4 %id) | |||
TI_1948142491 | .b | 1482 to 2457 | 1113 to 128 | 986/1357 (72 %) | 49 diff (96.4 %id) | ||||
TI_1948142492 | .b | 1590 to 2457 | 1002 to 131 | 872/1299 (67 %) | 30 diff (97.7 %id) | ||||
TI_1948142823 | .c-u | 1342 to 2040 | 113 to 810 | 698/1333 (52 %) | 6 diff (99.6 %id) | ||||
TI_1948142824 | .c-u | 1342 to 2236 | 113 to 1010 | AAA | 898/1323 (67 %) | 7 diff (99.5 %id) | |||
TI_1948142825 | .b | 1438 to 2457 | 1130 to 127 | 1004/1300 (77 %) | 39 diff (97.0 %id) | ||||
TI_1948142826 | .b | 1471 to 2457 | 1117 to 127 | 991/1435 (69 %) | 33 diff (97.8 %id) | ||||
TI_1948155515 | .c-u | 1445 to 1958 | 220 to 735 | 516/1366 (37 %) | 50 diff (96.4 %id) | ||||
DR002372 | fetal brain | .d | 1 to 586 | 1 to 586 | G2E P3A | tiling clone, | 586/586 (100 %) | 5 diff (99.2 %id) | |
DR002144 | fetal brain | .c-u | 1328 to 1942 | 9 to 623 | 615/623 (98 %) | 6 diff (99.1 %id) | |||
BM145393 | leukopheresis | .a | 7377 to 7880 | 17 to 521 | tiling clone, | 505/532 (94 %) | 7 diff (98.7 %id) | ||
DB105228 | thymus | .a | 6069 to 6618 | 2 to 551 | capped | 550/550 (100 %) | 0 diff (100 %id) | ||
DB342821 | thymus | .a | 7882 to 8463 | 582 to 1 | 582/592 (98 %) | 0 diff (100 %id) | |||
TI_149286816 | .a | 3162 to 3869 | 789 to 84 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 706/1186 (59 %) | 10 diff (99.2 %id) | ||
TI_154077858 | .a | 1978 to 2585 | 671 to 65 | 607/672 (90 %) | 0 diff (100 %id) | ||||
TI_154164531 | .c-u | 2071 to 2837 | 77 to 824 | 748/893 (83 %) | 21 diff (97.7 %id) | ||||
BU681085 | lung | .a | 3340 to 3869 | 546 to 17 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 530/530 (100 %) | 0 diff (100 %id) | |
BM713201 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5630 to 6048 | 1 to 419 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 419/419 (100 %) | 0 diff (100 %id) | |
BM713201 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5630 to 6048 | 1 to 419 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 419/419 (100 %) | 0 diff (100 %id) | |
BM713325 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5630 to 6048 | 1 to 419 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 419/422 (99 %) | 1 diff (99.8 %id) | |
BM713325 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 5630 to 6048 | 1 to 419 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 419/422 (99 %) | 1 diff (99.8 %id) | |
BQ574154 | Chondrosarcoma Grade II, Left Pelvis | .b | 4086 to 4705 | 638 to 19 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 620/620 (100 %) | 2 diff (99.7 %id) | |
BQ574154 | Chondrosarcoma Grade II, Left Pelvis | .b | 4086 to 4705 | 638 to 19 | AAA | Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) | 620/620 (100 %) | 2 diff (99.7 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c-u, .d, .e, .f, .g-u, .h, .i | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes C |